Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Ocata Therapeutics
ClinicalTrials.gov Identifier:
NCT01344993
First received: April 28, 2011
Last updated: April 27, 2015
Last verified: April 2015